speb/financial-data huggingface dataset:
ASML.AS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 2355000000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2355000000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2355000000.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 2355000000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 2355000000.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -1500000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Net Interest Income: 49200000.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 400000.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 400000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 49200000.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 800000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Net PPE: 7518300000.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -415000000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 12320500000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 153400000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Non Current Accrued Expenses: 436700000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 1861000000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 5736500000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 5400600000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1861000000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 335900000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 1443400000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 2979200000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Normalized Income: 2355000000.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -58600000.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -34900000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Operating Income: 2737900000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Operating Revenue: 7741500000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 393200230.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1848600000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 18123900000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 591600000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 859200000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Other Properties: 7518300000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 789000000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 5200000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Pretax Income: 2787100000.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 59600000.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -1500000.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -415000000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Receivables: 5547500000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3561800000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 241300000.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -2592600000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Research And Development: 1161100000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 280700000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Share Issued: 393200230.00
ASML.AS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 40000000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 17500700000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 12320500000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ASML.AS income_statement (quarterly, 2025-03-31) — Tax Provision: 465100000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.17
ASML.AS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 143200000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Total Assets: 45478800000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 21181700000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Total Debt: 3681000000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 17500700000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Total Expenses: 5003600000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 27978100000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 17954400000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 9854200000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 2737900000.00
ASML.AS income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -49200000.00
ASML.AS balance_sheet (quarterly, 2025-03-31) — Working Capital: 9400500000.00
ASML.AS income_statement (quarterly, 2025-06-30) — +Operating Expense: 905800000.00
ASML.AS income_statement (quarterly, 2025-06-30) — +Total Revenue: 7691700000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 4996900000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 16500000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 9098400000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -988300000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 7243500000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 7248900000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -714400000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -2202700000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -987400000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 1346000000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -1888300000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1844100000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 17618200000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 36400000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -1485200000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 3648000000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Current Assets: 26710500000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 18616000000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 122100000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Deferred Tax: 122100000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 375400000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 375400000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2676200000.00
ASML.AS income_statement (quarterly, 2025-06-30) — EBIT: 3274100000.00
ASML.AS income_statement (quarterly, 2025-06-30) — EBITDA: 3649500000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest Net Of Tax: 88800000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -90700000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -10800000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — End Cash Position: 7243500000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -2202700000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 357700000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Goodwill: 4588600000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 5154300000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 7661000000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Gross Profit: 4043700000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Inventory: 11575800000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3698900000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -987400000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1029200000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 36400000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Loans Receivable: 17800000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 3698900000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 3698900000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 1029200000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -1448800000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Net Income: 2676200000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2676200000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2676200000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2676200000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2676200000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 2676200000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2676200000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -573500000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Net Interest Income: 24800000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -39500000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -39500000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 24800000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 900000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Net PPE: 7661000000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -414800000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 12463900000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 175100000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Non Current Accrued Expenses: 434100000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 1830400000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 4481900000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 4187100000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 1830400000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 294800000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 1444900000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 3649500000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Normalized Income: 2676200000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1346000000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -90700000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Operating Income: 3137900000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Operating Revenue: 7691700000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 388147674.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1966200000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 18616000000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 565700000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 843700000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Other Properties: 7661000000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Other Receivables: 806400000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 5400000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Pretax Income: 3162700000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 99700000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -573500000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -414800000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Receivables: 5919600000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 3648000000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 375400000.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -1485200000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Research And Development: 607100000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 298700000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Share Issued: 388147674.00
ASML.AS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 35100000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 17618200000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 12463900000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ASML.AS income_statement (quarterly, 2025-06-30) — Tax Provision: 575300000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.18
ASML.AS balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 98500000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Total Assets: 44849100000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 21317100000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Total Debt: 3698900000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 17618200000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Total Expenses: 4553800000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 27230900000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 18138600000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 8614900000.00
ASML.AS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 3137900000.00
ASML.AS balance_sheet (quarterly, 2025-06-30) — Working Capital: 8094500000.00
ASML.AS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1411900000.00
ASML.AS income_statement (quarterly, 2025-09-30) — +Total Revenue: 7516000000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 5364300000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 3100000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 7243500000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -315400000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 5126500000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 5128200000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -619600000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -742000000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1927800000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 559100000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1903300000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2110700000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 18993500000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 35300000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -172200000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 3635700000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Current Assets: 25146300000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 19224900000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -55300000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Deferred Tax: -55300000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 274600000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 274600000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2124500000.00
ASML.AS income_statement (quarterly, 2025-09-30) — EBIT: 2468400000.00
ASML.AS income_statement (quarterly, 2025-09-30) — EBITDA: 2743000000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest Net Of Tax: 78900000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -80800000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -6300000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — End Cash Position: 5126500000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -742000000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 243700000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Goodwill: 4588600000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 5144300000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 8027200000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Gross Profit: 3880300000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Inventory: 11762800000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2704700000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1927800000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 2336200000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 35300000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 15000000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Loans Receivable: 190000000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 2704700000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2704700000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 15000000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -500000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 2336200000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -1210000000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -136900000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Net Income: 2124500000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2124500000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2124500000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2124500000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2124500000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2124500000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2124500000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -19500000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Net Interest Income: 19400000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 3500000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 14500000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 14500000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 19400000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -405900000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Net PPE: 8027200000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -295900000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 13849200000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Non Current Accrued Expenses: 414500000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 1838600000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 3759500000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 3572300000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 1838600000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 187200000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 1686000000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 2743000000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Normalized Income: 2124500000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 559100000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -80800000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Operating Income: 2468400000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Operating Revenue: 7516000000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 388147674.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1575100000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 19224900000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 555700000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 918500000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Other Properties: 8027200000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1032900000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 1700000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Pretax Income: 2487800000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 138600000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -1210000000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -19500000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 3500000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -295900000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Receivables: 6680200000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 3635700000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 274600000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -500000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -172200000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Research And Development: 1108700000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Sale Of Business: -1210000000.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 3500000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 303200000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Share Issued: 388147674.00
ASML.AS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 57700000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 18993500000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 13849200000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ASML.AS income_statement (quarterly, 2025-09-30) — Tax Provision: 442200000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.18
ASML.AS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 93000000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Total Assets: 45097100000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 21698200000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2704700000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 18993500000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Total Expenses: 5047600000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 26103600000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 19950800000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 6878700000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 2468400000.00
ASML.AS income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: -19400000.00
ASML.AS balance_sheet (quarterly, 2025-09-30) — Working Capital: 5921400000.00
ASML.AS income_statement (annual, 2025-12-31) — +Operating Expense: 5956600000.00
ASML.AS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1637500000.00
ASML.AS income_statement (annual, 2025-12-31) — +Total Revenue: 32667300000.00
ASML.AS income_statement (quarterly, 2025-12-31) — +Total Revenue: 9718100000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Accounts Payable: 3521800000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3521800000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 3023000000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 3023000000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -4926500000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -4926500000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4107100000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4107100000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ASML.AS cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 49700000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 28000000.00
ASML.AS income_statement (annual, 2025-12-31) — Basic Average Shares: 388500000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 386500000.00
ASML.AS income_statement (annual, 2025-12-31) — Basic EPS: 26.29
ASML.AS income_statement (quarterly, 2025-12-31) — Basic EPS: 7.35
ASML.AS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 12735900000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 5126500000.00
ASML.AS cash_flow (annual, 2025-12-31) — Capital Expenditure: -1631200000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -470400000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Capital Stock: 34900000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 34900000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 12916000000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 12916000000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 13321900000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 13321900000.00
ASML.AS cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -2550300000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -619200000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Cash Equivalents: 11780700000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 11780700000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Cash Financial: 1135300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Cash Financial: 1135300000.00
ASML.AS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -8670500000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2613300000.00
ASML.AS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -3777800000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1006300000.00
ASML.AS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 12658500000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 11410300000.00
ASML.AS cash_flow (annual, 2025-12-31) — Change In Account Payable: 13400000.00
ASML.AS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -237300000.00
ASML.AS cash_flow (annual, 2025-12-31) — Change In Inventory: -832500000.00
ASML.AS cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -561900000.00
ASML.AS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 1456500000.00
ASML.AS cash_flow (annual, 2025-12-31) — Change In Payable: 13400000.00
ASML.AS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -223900000.00
ASML.AS cash_flow (annual, 2025-12-31) — Change In Receivables: 1188300000.00
ASML.AS cash_flow (annual, 2025-12-31) — Change In Working Capital: 1026500000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 7640700000.00
ASML.AS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 1415500000.00
ASML.AS cash_flow (annual, 2025-12-31) — Changes In Cash: 210200000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Changes In Cash: 7790700000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Common Stock: 34900000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Common Stock: 34900000.00
ASML.AS cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -2550300000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -619200000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 19612200000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 19612200000.00
ASML.AS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 142300000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 32700000.00
ASML.AS cash_flow (annual, 2025-12-31) — Common Stock Payments: -5950000000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -1700000000.00
ASML.AS income_statement (annual, 2025-12-31) — Cost Of Revenue: 15409300000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 4649500000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2567300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2567300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Current Assets: 30616100000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Current Assets: 30616100000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Current Debt: 1681900000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Current Debt: 1681900000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1681900000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1681900000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 16006300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 16006300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 16006300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 16006300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Current Liabilities: 24263900000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 24263900000.00
ASML.AS cash_flow (annual, 2025-12-31) — Deferred Income Tax: 180700000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 118800000.00
ASML.AS cash_flow (annual, 2025-12-31) — Deferred Tax: 180700000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Deferred Tax: 118800000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 129900000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 129900000.00
ASML.AS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1025900000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 255200000.00
ASML.AS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1025900000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 255200000.00
ASML.AS income_statement (annual, 2025-12-31) — Diluted Average Shares: 388900000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 387000000.00
ASML.AS income_statement (annual, 2025-12-31) — Diluted EPS: 26.26
ASML.AS income_statement (quarterly, 2025-12-31) — Diluted EPS: 7.34
ASML.AS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 9609400000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2839600000.00
ASML.AS income_statement (annual, 2025-12-31) — EBIT: 11524400000.00
ASML.AS income_statement (quarterly, 2025-12-31) — EBIT: 3431100000.00
ASML.AS income_statement (annual, 2025-12-31) — EBITDA: 12550300000.00
ASML.AS income_statement (quarterly, 2025-12-31) — EBITDA: 3686300000.00
ASML.AS income_statement (annual, 2025-12-31) — Earnings From Equity Interest Net Of Tax: 216700000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest Net Of Tax: 16000000.00
ASML.AS cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 94600000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 300900000.00
ASML.AS cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -30100000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -1200000.00
ASML.AS cash_flow (annual, 2025-12-31) — End Cash Position: 12916000000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — End Cash Position: 12916000000.00
ASML.AS cash_flow (annual, 2025-12-31) — Financing Cash Flow: -8670500000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -2613300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Finished Goods: 2135100000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Finished Goods: 2135100000.00
ASML.AS cash_flow (annual, 2025-12-31) — Free Cash Flow: 11027300000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 10939900000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 135800000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 135800000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Goodwill: 4588600000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Goodwill: 4588600000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 5128700000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 5128700000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 3023000000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 3023000000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Gross PPE: 13161300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 13161300000.00
ASML.AS income_statement (annual, 2025-12-31) — Gross Profit: 17258000000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Gross Profit: 5068600000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 33600000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 33600000.00
ASML.AS cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 1621400000.00
ASML.AS income_statement (annual, 2025-12-31) — Interest Expense: 118300000.00
ASML.AS income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 118300000.00
ASML.AS income_statement (annual, 2025-12-31) — Interest Income: 223000000.00
ASML.AS income_statement (annual, 2025-12-31) — Interest Income Non Operating: 223000000.00
ASML.AS cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 114500000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -772800000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -772800000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Inventory: 11429300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Inventory: 11429300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Invested Capital: 24003100000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 24003100000.00
ASML.AS cash_flow (annual, 2025-12-31) — Investing Cash Flow: -3777800000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1006300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Investments And Advances: 2143300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 2143300000.00
ASML.AS cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 142300000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 32700000.00
ASML.AS cash_flow (annual, 2025-12-31) — Issuance Of Debt: 754200000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 739200000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Land And Improvements: 6421100000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 6421100000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Leases: 955200000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Leases: 955200000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Loans Receivable: 266100000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 266100000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Long Term Debt: 2709000000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 2709000000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2709000000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2709000000.00
ASML.AS cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 754200000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 739200000.00
ASML.AS cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1066700000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -1066000000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 2143300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 2143300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 5779600000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 5779600000.00
ASML.AS cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 1210000000.00
ASML.AS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -5807700000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -1667300000.00
ASML.AS income_statement (annual, 2025-12-31) — Net Income: 9609400000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Net Income: 2839600000.00
ASML.AS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 9609400000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2839600000.00
ASML.AS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 9609400000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2839600000.00
ASML.AS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 9609400000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2839600000.00
ASML.AS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 9609400000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2839600000.00
ASML.AS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 9609400000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 2839600000.00
ASML.AS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 9609400000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2839600000.00
ASML.AS cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -57600000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -22500000.00
ASML.AS income_statement (annual, 2025-12-31) — Net Interest Income: 104700000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Net Interest Income: 11200000.00
ASML.AS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -1703100000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -496600000.00
ASML.AS cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -312500000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -326800000.00
ASML.AS cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -312500000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -326800000.00
ASML.AS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 104700000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 11200000.00
ASML.AS cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -443500000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -39300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Net PPE: 8234800000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Net PPE: 8234800000.00
ASML.AS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1573600000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -447900000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 14483500000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 14483500000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 13300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 13300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Non Current Accrued Expenses: 432200000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Non Current Accrued Expenses: 432200000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 1719400000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 1719400000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 3549300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 3549300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 3366300000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 3366300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 1719400000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1719400000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 183000000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 183000000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 1653900000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 1653900000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 914500000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 914500000.00
ASML.AS income_statement (annual, 2025-12-31) — Normalized EBITDA: 12550300000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 3686300000.00
ASML.AS income_statement (annual, 2025-12-31) — Normalized Income: 9609400000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Normalized Income: 2839600000.00
ASML.AS cash_flow (annual, 2025-12-31) — Operating Cash Flow: 12658500000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 11410300000.00
ASML.AS cash_flow (annual, 2025-12-31) — Operating Gains Losses: 94600000.00
ASML.AS cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 300900000.00
ASML.AS income_statement (annual, 2025-12-31) — Operating Income: 11301400000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Operating Income: 3431100000.00
ASML.AS income_statement (annual, 2025-12-31) — Operating Revenue: 32667300000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Operating Revenue: 9718100000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 385417665.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 385417665.00
ASML.AS balance_sheet (annual, 2025-12-31) — Other Current Assets: 350500000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 350500000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 24263900000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 24263900000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 135800000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 135800000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 540100000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 540100000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 12700000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 12700000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Other Properties: 5400000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Other Properties: 5400000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Other Receivables: 1054100000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1054100000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 405900000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 405900000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Payables: 4008400000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Payables: 4008400000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 6575700000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 6575700000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Prepaid Assets: 861500000.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 861500000.00
ASML.AS income_statement (annual, 2025-12-31) — Pretax Income: 11406100000.00
ASML.AS income_statement (quarterly, 2025-12-31) — Pretax Income: 3442300000.00
ASML.AS balance_sheet (annual, 2025-12-31) — Properties: 0.00
ASML.AS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ASML.AS cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 469400000.00